Target N. V. Biotech, 10% Owner at MACROGENICS INC (MGNX), bought 300,000 shares at $5.96 ($1.8M) on 2022-11-22, disclosed to the SEC on 2022-11-25.
Open-market purchase of $1.8M MGNX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| MGNX | BUY | 2023-01-23 | $795K | — | Filing → |
| MTEM | BUY | 2022-05-18 | $236K | — | Filing → |
| RDUS | BUY | 2022-01-07 | $5.4M | — | Filing → |